Literature DB >> 30282836

High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.

Annemieke de Jong1, Ali Jabbari1, Zhenpeng Dai1, Luzhou Xing2, Dustin Lee1, Mei Mei Li1, Madeleine Duvic3, Maria Hordinsky4, David A Norris5, Vera Price6, Julian Mackay-Wiggan1, Raphael Clynes1, Angela M Christiano1,7.   

Abstract

Alopecia areata (AA) is an autoimmune disease in which cytotoxic T cells specifically target growing hair follicles. We used high-throughput TCR sequencing in the C3H/HeJ mouse model of AA and in human AA patients to gain insight into pathogenic T cell populations and their dynamics, which revealed clonal CD8+ T cell expansions in lesional skin. In the C3H/HeJ model, we observed interindividual sharing of TCRβ chain protein sequences, which strongly supports a model of antigenic drive in AA. The overlap between the lesional TCR repertoire and a population of CD8+NKG2D+ T cells in skin-draining lymph nodes identified this subset as pathogenic effectors. In AA patients, treatment with the oral JAK inhibitor tofacitinib resulted in a decrease in clonally expanded CD8+ T cells in the scalp but also revealed that many expanded lesional T cell clones do not completely disappear from either skin or blood during treatment with tofacitinib, which may explain in part the relapse of disease after stopping treatment.

Entities:  

Keywords:  Adaptive immunity; Autoimmunity; Dermatology; T-cell receptor

Year:  2018        PMID: 30282836      PMCID: PMC6237451          DOI: 10.1172/jci.insight.121949

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  65 in total

1.  Melanocytes: a possible autoimmune target in alopecia areata.

Authors:  Stephanie Trautman; Michele Thompson; Janet Roberts; Curtis T Thompson
Journal:  J Am Acad Dermatol       Date:  2009-09       Impact factor: 11.527

2.  Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.

Authors:  A Gilhar; Y Ullmann; T Berkutzki; B Assy; R S Kalish
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

3.  Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.

Authors:  Milène Kennedy Crispin; Justin M Ko; Brittany G Craiglow; Shufeng Li; Gautam Shankar; Jennifer R Urban; James C Chen; Jane E Cerise; Ali Jabbari; Mårten Cg Winge; M Peter Marinkovich; Angela M Christiano; Anthony E Oro; Brett A King
Journal:  JCI Insight       Date:  2016-09-22

4.  High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.

Authors:  Andreas Lossius; Jorunn N Johansen; Frode Vartdal; Harlan Robins; Benth Jūratė Šaltytė; Trygve Holmøy; Johanna Olweus
Journal:  Eur J Immunol       Date:  2014-09-16       Impact factor: 5.532

5.  Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.

Authors:  Ali Jabbari; Nhan Nguyen; Jane E Cerise; Grace Ulerio; Annemieke de Jong; Raphael Clynes; Angela M Christiano; Julian Mackay-Wiggan
Journal:  Exp Dermatol       Date:  2016-08       Impact factor: 3.960

6.  Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci.

Authors:  Regina C Betz; Lynn Petukhova; Stephan Ripke; Hailiang Huang; Androniki Menelaou; Silke Redler; Tim Becker; Stefanie Heilmann; Tarek Yamany; Madeliene Duvic; Maria Hordinsky; David Norris; Vera H Price; Julian Mackay-Wiggan; Annemieke de Jong; Gina M DeStefano; Susanne Moebus; Markus Böhm; Ulrike Blume-Peytavi; Hans Wolff; Gerhard Lutz; Roland Kruse; Li Bian; Christopher I Amos; Annette Lee; Peter K Gregersen; Bettina Blaumeiser; David Altshuler; Raphael Clynes; Paul I W de Bakker; Markus M Nöthen; Mark J Daly; Angela M Christiano
Journal:  Nat Commun       Date:  2015-01-22       Impact factor: 14.919

7.  PD-1 blockade induces responses by inhibiting adaptive immune resistance.

Authors:  Paul C Tumeh; Christina L Harview; Jennifer H Yearley; I Peter Shintaku; Emma J M Taylor; Lidia Robert; Bartosz Chmielowski; Marko Spasic; Gina Henry; Voicu Ciobanu; Alisha N West; Manuel Carmona; Christine Kivork; Elizabeth Seja; Grace Cherry; Antonio J Gutierrez; Tristan R Grogan; Christine Mateus; Gorana Tomasic; John A Glaspy; Ryan O Emerson; Harlan Robins; Robert H Pierce; David A Elashoff; Caroline Robert; Antoni Ribas
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

8.  Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.

Authors:  Ali Jabbari; Jane E Cerise; James C Chen; Julian Mackay-Wiggan; Madeleine Duvic; Vera Price; Maria Hordinsky; David Norris; Raphael Clynes; Angela M Christiano
Journal:  EBioMedicine       Date:  2016-03-31       Impact factor: 8.143

9.  Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes.

Authors:  Howard R Seay; Erik Yusko; Stephanie J Rothweiler; Lin Zhang; Amanda L Posgai; Martha Campbell-Thompson; Marissa Vignali; Ryan O Emerson; John S Kaddis; Dave Ko; Maki Nakayama; Mia J Smith; John C Cambier; Alberto Pugliese; Mark A Atkinson; Harlan S Robins; Todd M Brusko
Journal:  JCI Insight       Date:  2016-12-08

10.  High-throughput sequencing of islet-infiltrating memory CD4+ T cells reveals a similar pattern of TCR Vβ usage in prediabetic and diabetic NOD mice.

Authors:  Idania Marrero; David E Hamm; Joanna D Davies
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more
  9 in total

1.  A transcriptomic map of murine and human alopecia areata.

Authors:  Nicholas Borcherding; Sydney B Crotts; Luana S Ortolan; Nicholas Henderson; Nicholas L Bormann; Ali Jabbari
Journal:  JCI Insight       Date:  2020-07-09

Review 2.  Mouse Models of Alopecia Areata: C3H/HeJ Mice Versus the Humanized AA Mouse Model.

Authors:  Amos Gilhar; Rimma Laufer Britva; Aviad Keren; Ralf Paus
Journal:  J Investig Dermatol Symp Proc       Date:  2020-11

Review 3.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

Review 4.  Targeting the Janus Kinase Family in Autoimmune Skin Diseases.

Authors:  Michael D Howell; Fiona I Kuo; Paul A Smith
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

5.  Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells.

Authors:  Celestine N Wanjalla; Wyatt J McDonnell; Ramesh Ram; Abha Chopra; Rama Gangula; Shay Leary; Mona Mashayekhi; Joshua D Simmons; Christian M Warren; Samuel Bailin; Curtis L Gabriel; Liang Guo; Briana D Furch; Morgan C Lima; Beverly O Woodward; LaToya Hannah; Mark A Pilkinton; Daniela T Fuller; Kenji Kawai; Renu Virmani; Aloke V Finn; Alyssa H Hasty; Simon A Mallal; Spyros A Kalams; John R Koethe
Journal:  Cell Rep Med       Date:  2021-02-16

Review 6.  Immunopathogenesis of alopecia areata.

Authors:  Jadesola Jadé Temitope Olayinka; Jillian M Richmond
Journal:  Curr Res Immunol       Date:  2021-02-06

Review 7.  Pathomechanisms of immune-mediated alopecia.

Authors:  Alessandra Anzai; Eddy Hsi Chun Wang; Eunice Y Lee; Valeria Aoki; Angela M Christiano
Journal:  Int Immunol       Date:  2019-07-13       Impact factor: 5.071

8.  High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis.

Authors:  Xiaolan Ye; Zhe Wang; Qiang Ye; Jing Zhang; Ping Huang; Jingying Song; Yiwen Li; Hongjuan Zhang; Feifeng Song; Zixue Xuan; Kejian Wang
Journal:  Front Immunol       Date:  2020-08-06       Impact factor: 7.561

Review 9.  Alopecia Areata: An Autoimmune Disease of Multiple Players.

Authors:  Poonkiat Suchonwanit; Chaninan Kositkuljorn; Cherrin Pomsoong
Journal:  Immunotargets Ther       Date:  2021-07-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.